Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quantumscape Corp (QS) vs Tilray Brands Inc (TLRY) Price & Performance

Quantumscape CorpTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Quantumscape Corp vs Tilray Brands Inc — how do they compare? Quantumscape Corp trades at $5.54 (market cap $3.72B), while Tilray Brands Inc trades at $4.2 (market cap $524.07M). The key difference: Quantumscape Corp is far larger — about 7.1× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.

QSTLRY
Market Cap
$3.72B$524.07M
Sector
Consumer CyclicalHealth
52-Week High
$18.44$21.00
52-Week Low
$5.86$4.23
Enterprise Value
$2.89B$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Quantumscape Corp

QuantumScape (QS) trades at $6.05, up 3.24% on the day, amid a bearish technical signal and negative profitability metrics. The company reported a net loss of $435.05 million in 2025, with negative ROE and ROA, while cash flow remains dependent on financing activities. Recent news highlights a joint research agreement with Honda, providing optimism around solid-state battery development, though earnings misses in recent quarters temper near-term expectations.

The outlook remains speculative with high execution risk as QS transitions from R&D to commercialization. Investor sentiment is cautious, reflected in analyst holds and sells, but partnerships like Honda offer long-term potential. Key risks include sustained losses, EV market demand volatility, and manufacturing scalability challenges against established competitors.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quantumscape Corp

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.

Read more on QS

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY